Search results for "Highlights"


 
Results 51 - 60 of about 465 for "Highlights".
Sort by: Relevance | Newest | Oldest

COVID-19 boosters associated with transient increases in glycemia, study finds

A small cohort study of patients with type 1 diabetes who received COVID-19 booster vaccines found significant increases in their blood glucose levels on the second and third day after vaccination.
https://diabetes.acponline.org/archives/2023/10/13/3.htm
13 Oct 2023

GLP-1 receptor agonists associated with better primary CV prevention vs. DPP-4 inhibitors

A retrospective study compared cardiovascular (CV) outcomes among patients adding glucagon-like peptide-1 (GLP-1) receptor agonists, sodium-glucose cotransporter-2 inhibitors, or dipeptidyl peptidase-4 (DPP-4) inhibitors to metformin, sulfonylurea, or insulin treatment alone or in combination.
https://diabetes.acponline.org/archives/2023/05/12/3.htm
12 May 2023

Afternoon physical activity linked to greater HbA1c reduction than other times of day

A secondary analysis of the Look AHEAD (Action for Health in Diabetes) study found that participants who performed more moderate to vigorous physical activity in the afternoon versus other times of day had the greatest reduction in HbA1c compared to those who were inactive.
https://diabetes.acponline.org/archives/2023/06/09/2.htm
9 Jun 2023

More than a quarter of diabetes patients have diabetic retinopathy, study estimates

Researchers calculated that in 2021, 9.60 million people in the U.S. had diabetic retinopathy, including 1.84 million with vision-threatening diabetic retinopathy, based on data from the National Health and Nutrition Examination Survey and insurance claims, among other sources.
https://diabetes.acponline.org/archives/2023/07/14/2.htm
14 Jul 2023

Portable point-of-care screening may help improve diabetic retinopathy diagnosis

An Australian study found that 39.6% of patients at high-risk diabetes clinics had diabetic retinopathy and 15.8% had vision-threatening diabetic retinopathy, previously undiagnosed in 59.3% and 62.8%, respectively.
https://diabetes.acponline.org/archives/2023/09/08/3.htm
8 Sep 2023

Vitamin D may reduce risk of progression to diabetes from prediabetes

In adults with prediabetes, high-dose vitamin D was associated with a 12% to 15% reduced risk for diabetes compared with placebo, a systematic review and meta-analysis found, but an editorial cautioned about the uncertain risk of adverse effects.
https://diabetes.acponline.org/archives/2023/02/10/3.htm
10 Feb 2023

SGLT-2 inhibitors, GLP-1 receptor agonists beat DPP-4s, sulfonylureas in pragmatic trial

Veterans with diabetes who started sodium-glucose cotransporter-2 (SGLT-2) inhibitors or glucagon-like peptide-1 (GLP-1) receptor agonists had fewer major adverse cardiovascular events than those initiating dipeptidyl peptidase-4 (DPP-4) inhibitors or sulfonylureas.
https://diabetes.acponline.org/archives/2023/08/11/3.htm
11 Aug 2023

ADA, KDIGO offer consensus statements on managing diabetes and chronic kidney disease

The American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) provided specific advice on use of metformin, sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and nonsteroidal mineralocorticoid receptor antagonists in patients with diabetes and chronic kidney disease.
https://diabetes.acponline.org/archives/2022/10/14/1.htm
14 Oct 2022

CT as effective as angiography as first test for patients with diabetes, chest pain

Patients with diabetes and stable chest pain had no difference in major adverse cardiac events if they underwent cardiac CT first when they were referred for invasive coronary angiography, and they had fewer procedure-related complications with a CT-first strategy.
https://diabetes.acponline.org/archives/2023/10/13/2.htm
13 Oct 2023

HbA1c levels above 9% may be associated with higher dementia risk

A cohort study found higher dementia risk among type 2 diabetes patients ages 50 years and older whose HbA1c levels were usually in the 9% to 10% or 10% and above range compared to those with tighter glycemic control.
https://diabetes.acponline.org/archives/2023/05/12/2.htm
12 May 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next